Drug profile · INN
amifampridine
AMIFAMPRIDINE SERB
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
amifampridine (AMIFAMPRIDINE SERB) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN amifampridine
Brand AMIFAMPRIDINE SERB
Route ORAL
Formulation TABLET
ATC code N07XX05
Frequently asked questions
What is amifampridine?
amifampridine (AMIFAMPRIDINE SERB) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amifampridine?
AMIFAMPRIDINE SERB is a marketed brand name for amifampridine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amifampridine?
amifampridine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.